Anzu Special Acquisition Corp I
Status: Deal Closed
U=S+W/3
W=S@11.5
| IPO Proceeds, $M | $425.00M |
|---|---|
| IPO Date | Mar 2, 2021 |
| CEO | Dr. Whitney Haring-Smith |
| Left Lead | BofA Securities |
| IPO Cash in Trust | 100.0% |
| SPAC Tenor | 24+6 |
| IPO Sector |
Industrial
High-quality businesses with transformative technologies for industrial applications |
| IPO Geography | Global |
| Target Company | Envoy Medical |
| Deal Announced | Apr 18, 2023 |
| Deal Size, $M | $150.00M |
| Deal Sector | Healthcare |
| Deal Geography | US/Canada |
| SEC Filings | www.sec.gov |
| Approval Vote | Sep 27, 2023 |
| Amendment Vote | Sep 29, 2023 |
| Closing Date | Sep 29, 2023 |
Formerly ANZU
COCH
COCHW
| Price | $2.09 |
|---|---|
| Last closing price | $2.15 |
| H/L, today | $2.04 / $2.21 |
| H/L, 52-week | $1.02 / $5.55 |
| Volume, today | 8,125 |
| Volume, 3-month avg. | N/A |
Sign up for Free Trial
No credit card required
Sign in for more on Anzu Special Acquisition Corp I:
- Structure and cap table
- 5 directors & officers
- 40 filings and events
- 2 underwriters
Structure
Sign in to view structure, cap table, and calendar of events.
Team
| Name | Age | Title |
|---|---|---|
| Dr. Whitney Haring-Smith | 36 | CEO and Director |
| Daniel J. Hirsch | 48 | CFO and Director |
| Priya Cherian Huskins | 48 | Director |
| Susan J. Kantor | 65 | Director |
| Diane L. Dewbrey | 58 | Director |
Sign in to view team biographies and more sponsor and affiliate data.
Advisors
Underwriters
| BofA Securities | Joint BR | 25,200,000 | units |
| Barclays | Joint BR | 16,800,000 | |
| 42,000,000 | units | ||
| Up-Front UW fee | 2.00 | % | |
| Deferred UW fee |
3.50 | % |
Sign in to view more advisor data.
Deal
Sign in to view merger details and deal financials.